Compare CYTK & POWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYTK | POWL |
|---|---|---|
| Founded | 1997 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 7.0B |
| IPO Year | 2004 | 1995 |
| Metric | CYTK | POWL |
|---|---|---|
| Price | $56.27 | $142.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 4 |
| Target Price | $109.42 | ★ $267.50 |
| AVG Volume (30 Days) | ★ 1.9M | 747.0K |
| Earning Date | 11-04-2026 | 11-16-2026 |
| Dividend Yield | N/A | ★ 0.25% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 3.81 |
| Revenue | $13,368,000.00 | ★ $448,716,000.00 |
| Revenue This Year | $87.17 | $7.85 |
| Revenue Next Year | $170.90 | $24.54 |
| P/E Ratio | ★ N/A | $37.02 |
| Revenue Growth | N/A | ★ 13.34 |
| 52 Week Low | $53.58 | $121.13 |
| 52 Week High | $88.31 | $612.50 |
| Indicator | CYTK | POWL |
|---|---|---|
| Relative Strength Index (RSI) | 38.80 | 41.18 |
| Support Level | N/A | $121.13 |
| Resistance Level | $66.62 | $190.01 |
| Average True Range (ATR) | 2.69 | 8.84 |
| MACD | -0.24 | -0.10 |
| Stochastic Oscillator | 24.29 | 41.50 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Powell Industries Inc is a United States-based company that develops, designs, manufactures, and services custom-engineered equipment and systems for electrical energy distribution, control, and monitoring. The company's principal products comprise integrated power control room substations, custom-engineered modules, electrical houses, traditional and arc-resistant distribution switchgear and control gear, and so on. These products are applied in oil and gas refining, offshore oil and gas production, petrochemical, pipeline, terminal, mining and metals, light-rail traction power, electric utility, pulp and paper, and other heavy industrial markets. The company generates the majority of its sales from the United States, and the rest from Canada, Europe, Asia Pacific, and other regions.